LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 434 | 0.0% | 0.00% | – |
Q2 2023 | $1 | 0.0% | 434 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 434 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 434 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 434 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 434 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 434 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | +100.0% | 434 | -25.6% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 583 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 583 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 583 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 583 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -50.0% | 583 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | +33.3% | 583 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | -25.0% | 583 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -33.3% | 583 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | -14.3% | 583 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | +40.0% | 583 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | – | 583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |